Science & Technology
Epigenetic phenotyping from liquid biopsy for preeclampsia risk classification during the first trimester
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R41HL172464-01
Award Ceiling
$306K
Award Floor
$306K
Close Date
Dec 31, 2024
Total Funding
$306K
Expected Awards
1
Posted Date
Jan 15, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-1R41HL172464-01
Description
STTR Phase Phase I award: "Epigenetic phenotyping from liquid biopsy for preeclampsia risk classification during the first trimester" awarded to KANONA, INC. in Scotch Plains, New Jersey. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $306,223. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.